Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others... Show more
Carpenter Technology Corporation stands as a global leader in high-performance specialty alloys, serving critical applications in aerospace, defense, medical, and energy sectors. Its recent reclassification to the GICS Aerospace & Defense sector highlights a revenue concentration exceeding 50% from these high-margin areas, positioning it favorably amid industry tailwinds. The company's competitive edge lies in its advanced manufacturing capabilities, including premium alloys for jet engines and medical implants, supported by a robust product pipeline and innovation in additive manufacturing. Market share trends show steady gains in commercial aerospace, driven by partnerships with major OEMs (original equipment manufacturers). Medium-term expansion strategies emphasize capacity investments and cost efficiencies, aiming for operating margin expansion to over 25%. Structural risks include supply chain vulnerabilities for rare metals, but diversification into medical devices provides a buffer.
The Q3 FY2026 earnings release on April 29, 2026, looms as a pivotal event, with expectations for continued operating income growth and potential guidance updates on aerospace order backlogs. This could reinforce investor confidence if results align with the company's raised FY2026 operating income target of $680-700 million. Analyst sentiment has turned increasingly bullish, evidenced by recent upgrades such as KeyBanc's price target hike to $453 and Susquehanna's initiation at $470 with a Buy rating. Consensus ratings hold at Strong Buy across 8-11 analysts, with average price targets ranging from $403 to $439, implying moderate upside potential. Other catalysts include accelerating aerospace demand from commercial engine programs and potential defense contract wins amid geopolitical tensions. Regulatory approvals for new alloys and capital allocation decisions, such as share buybacks, could further shape sentiment.
Carpenter Technology's trajectory is closely tied to aerospace and defense cycles, where commercial aviation recovery and sustained military spending provide tailwinds. Rising global defense budgets, fueled by geopolitical developments, bolster demand for high-performance alloys. In medical, elective procedure volumes hinge on consumer demand and healthcare spending. Macro factors like interest rates influence customer capex (capital expenditures) in aerospace OEMs, with higher rates potentially delaying orders. Commodity price volatility—particularly titanium and nickel—directly impacts input costs, though hedging mitigates some exposure. Broader inflation trends affect operating margins, while technology shifts toward sustainable aviation fuels spur innovation opportunities. A favorable regulatory climate for U.S. manufacturing further supports domestic positioning.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. Designed to spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a wide range of tradable instruments, it leverages advanced machine learning models trained on historical price data and market patterns. Users benefit from searchable prediction categories, historical performance context, and customizable alerts for real-time notifications on shifting momentum. This neutral, data-driven approach empowers informed decision-making in dynamic markets. Explore the Trend Prediction Engine today to enhance your trading strategy.
For FY2026, Carpenter Technology's guidance points to operating income of $680-700 million, underpinned by aerospace volume growth and pricing discipline. Analysts forecast 7% annual sales growth and EBITDA expansion at 18% CAGR through 2028, driven by margin leverage to 32%. Long-term themes include market expansion in emerging aerospace regions, cost structure optimization via automation, and margin sustainability through premium product mix. Technology transitions like additive manufacturing and hydrogen-compatible alloys position CRS for energy sector opportunities. Competitive threats from low-cost producers loom, but U.S.-centric supply chains offer advantages. Regulatory developments in defense procurement and medical device standards will influence pipelines. Consensus expectations remain optimistic, with price targets reflecting structural demand drivers over cyclical risks. Capital allocation priorities, including debt reduction and dividends, will be key to watch.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a manufacturer of specialty metals
Industry MetalFabrication
A.I.dvisor indicates that over the last year, CRS has been closely correlated with ATI. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRS jumps, then ATI could also see price increases.
| Ticker / NAME | Correlation To CRS | 1D Price Change % |
|---|---|---|
| CRS | 100% | +1.62% |
| CRS (2 stocks) | 99% Closely correlated | -1.80% |
| Metal Fabrication (18 stocks) | 33% Loosely correlated | -3.71% |
| Producer Manufacturing (349 stocks) | 8% Poorly correlated | -0.07% |
CRS saw its Momentum Indicator move above the 0 level on May 22, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned positive. In of the 85 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for CRS just turned positive on May 26, 2026. Looking at past instances where CRS's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRS advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 332 cases where CRS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 15 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 22 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
CRS broke above its upper Bollinger Band on June 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CRS's P/B Ratio (14.124) is very high in comparison to the industry average of (3.802). P/E Ratio (61.871) is within average values for comparable stocks, (49.350). CRS's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.225). Dividend Yield (0.001) settles around the average of (0.013) among similar stocks. P/S Ratio (9.794) is also within normal values, averaging (4252.340).